Trial Search Results

Emergency Ventilator Splitting Between Two or More Patients (COVID-19)

The purpose of this study is to develop a safe, easily scalable, and simple method to split a single ventilator for use amongst two or more patients, thus serving as a capacity bridge to save patient lives until manufacturers can produce enough ventilators.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):

Intervention(s):

  • Device: Emergency Ventilator Splitter

Phase:

N/A

Eligibility


Inclusion Criteria:

   - Phase I

      - Undergoing routine thoracic surgery which will include the use of a dual lumen
      endotracheal tube at Stanford.

   - Phase II

      - Able to give consent

      - On venovenous extracorporeal membrane oxygenation for reason other than COVID-19

   - Phase III

      - Able to give consent

      - Infected with COVID-19 and will likely require mechanical ventilation.

Exclusion Criteria:

   - Phase I

      - Significant cardiac comorbidities

      - Liver disease

   - Phase II

      - Significant cardiac comorbidities

      - Pre or Post-transplant patient

      - Infection with COVID-19

   - Phase III

      - Co-infection with disease aside from COVID-19

      - Severely ill requiring high ventilator requirements and not stable for ventilator
      splitting

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Not Recruiting